Month: February 2018

Our Reader Score [Total: 0 Average: 0] Recent phase 3 clinical trials compared the efficacy and safety of a novel two-drug regimen, with the standard three-drug antiretroviral therapy for HIV. Antiretroviral therapy (ART), comprised of two nucleoside reverse transcriptase inhibitors (NRTIs) and a third drug, is the first- and second-line treatment for patients with an
0 Comments
A new anti-stroke drug has now successfully passed preliminary clinical trials, leading its developers to enthuse over its potential as a more effective treatment, less likely to be accompanied by unwanted health events. Could this experimental drug protect against the adverse effects of traditional anti-stroke treatments? Stroke, a cardiovascular event, occurs when the brain’s supply
0 Comments
Researchers from Colorado and Florida have found that a drug commonly used to control blood pressure could have another use: preventing and treating type 1 diabetes. Researchers have identified a blood pressure drug that could help to prevent type 1 diabetes. The new research — co-authored by Dr. Aaron Michels, an associate professor of medicine
0 Comments
Our Reader Score [Total: 0 Average: 0] Researchers from East Carolina University performed a study using mice to look at the effects of exercise in reversing metabolic dysfunction in Alzheimer’s disease. Alzheimer’s disease (AD) is a neurological degenerative condition that leads to cognitive decline and memory loss. Alzheimer’s disease is strongly associated with aging and
0 Comments
When someone is first diagnosed with type 1 diabetes and insulin treatment starts, their blood sugar can stay at near-normal levels, and their diabetes symptoms vanish. This near-normal blood sugar condition is achieved with decreasing amounts of insulin, and some people manage to come off insulin temporarily. This status quo is known as the honeymoon
0 Comments
Our Reader Score [Total: 0 Average: 0] An episodic migraine is a debilitating headache disorder with few effective and safe preventative treatments available. Researchers in this study conducted a trial on erenumab, to determine its effectiveness in providing relief for people suffering from episodic migraines. Migraines are defined as a debilitating headache disorder that manifests
0 Comments